Additionally, 3-(4-hydroxy-3-methoxyphenyl)propionic acid, a metabolite produced by gut microbiota, activated GPR41, contributing to anti-obesity effects and the suppression of hepatic steatosis (34). Here, FFAR3 is linked to fatty liver disease.